Skip to main content
About us
Overview
Who We Are
Leadership Team
Board of Directors
Advisory Board
AI platform technologies
Pipeline
Overview
EVX-01 clinical trial
Investors
Overview
News & Events
Press Releases
Stay in Touch
Careers
Contact
Information Request Form
Contact us
Site Search
open mobile navigation
Press Releases
close mobile navigation
About us
Overview
Who We Are
Leadership Team
Board of Directors
Advisory Board
AI platform technologies
Pipeline
Overview
EVX-01 clinical trial
Investors
Overview
News & Events
Press Releases
Stay in Touch
Careers
Contact
Information Request Form
Contact us
Normal
Press release year list
2021
2020
2019
2018
2017
2016
12/23/2020
Evaxion Biotech doses first patient in Phase I/IIa melanoma trial of cancer vaccine EVX-02 in combination with checkpoint inhibitors
Download
PDF format download (opens in new window)
12/17/2020
Evaxion Biotech appoints Marianne Søgaard as Chairwoman
Download
PDF format download (opens in new window)
12/09/2020
EU Boosts Evaxion’s Artificial Intelligence Vaccine Research
12/09/2020
Evaxion Biotech announces publication in Nature Communications describing improved selection of immunotherapy targets
10/22/2020
SB3000 partners with Evaxion biotech to provide rapid scale up for commercial production of corona virus vaccines with its continuous manufacturing technology
10/02/2020
Evaxion Biotech Launches New AI Powered Platform, RAVEN, to Enable Faster Response to Emerging Viral Pandemics
07/22/2020
Evaxion Biotech among the top 16 global companies using artificial intelligence to revolutionize drug discovery, according to experts from Frost & Sullivan